IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GUERINI ROCCO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.698
AS - Asia 7.307
NA - Nord America 6.800
SA - Sud America 718
AF - Africa 219
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.552
DE - Germania 3.781
CN - Cina 2.444
SG - Singapore 2.376
IT - Italia 1.537
GB - Regno Unito 1.144
HK - Hong Kong 693
BR - Brasile 562
VN - Vietnam 527
RU - Federazione Russa 478
SE - Svezia 335
FR - Francia 334
IN - India 309
NL - Olanda 253
IE - Irlanda 178
FI - Finlandia 173
BD - Bangladesh 170
ID - Indonesia 151
CA - Canada 142
JP - Giappone 121
TR - Turchia 107
KR - Corea 95
ES - Italia 67
DK - Danimarca 60
CI - Costa d'Avorio 58
MX - Messico 56
AT - Austria 52
AR - Argentina 50
AU - Australia 48
PH - Filippine 46
PL - Polonia 45
UA - Ucraina 44
ZA - Sudafrica 42
BE - Belgio 38
IQ - Iraq 36
EC - Ecuador 35
TW - Taiwan 34
EG - Egitto 29
MY - Malesia 27
CH - Svizzera 26
PT - Portogallo 24
GR - Grecia 23
IR - Iran 22
TH - Thailandia 21
CO - Colombia 19
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
KE - Kenya 17
PK - Pakistan 17
UZ - Uzbekistan 17
CR - Costa Rica 14
MA - Marocco 14
CL - Cile 13
VE - Venezuela 13
NG - Nigeria 12
NO - Norvegia 12
NZ - Nuova Zelanda 12
JO - Giordania 10
IL - Israele 9
LT - Lituania 9
PE - Perù 9
SN - Senegal 9
TN - Tunisia 9
RO - Romania 8
RS - Serbia 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
HN - Honduras 7
HU - Ungheria 7
AZ - Azerbaigian 6
ET - Etiopia 6
DZ - Algeria 5
MD - Moldavia 5
OM - Oman 5
PY - Paraguay 5
SC - Seychelles 5
AL - Albania 4
GE - Georgia 4
GH - Ghana 4
GT - Guatemala 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
LU - Lussemburgo 4
PA - Panama 4
SI - Slovenia 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
BW - Botswana 3
DO - Repubblica Dominicana 3
EE - Estonia 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
Totale 23.768
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 3.488
Singapore 1.254
Dallas 1.178
Southend 937
Ashburn 899
Hong Kong 597
Milan 452
San Jose 444
Beijing 333
Chandler 325
Hefei 285
Council Bluffs 261
Fairfield 220
Los Angeles 214
Dublin 173
Ho Chi Minh City 167
Santa Clara 165
Princeton 159
Hanoi 146
New York 140
Wilmington 134
Lauterbourg 129
Bengaluru 116
Guangzhou 116
Jakarta 112
Seattle 112
Woodbridge 107
Helsinki 106
Ann Arbor 102
Rome 100
Houston 99
Moscow 95
Buffalo 94
Cambridge 87
Munich 82
Tokyo 81
Dearborn 77
Shanghai 77
Boardman 73
Istanbul 71
Toronto 68
Nanjing 67
Seoul 63
São Paulo 62
Des Moines 61
Abidjan 58
Nuremberg 48
Cangzhou 46
Jinan 45
Chicago 44
Shenyang 44
Naples 42
Changsha 38
Phoenix 38
The Dalles 36
Shenzhen 35
Turin 34
Columbus 33
Lappeenranta 32
Tianjin 32
London 31
Redwood City 30
Vienna 30
Atlanta 29
Hangzhou 29
Washington 29
Orem 28
Amsterdam 27
Hyderabad 27
San Diego 26
Bologna 24
Berlin 23
Da Nang 23
Brussels 22
Haiphong 22
Fuzhou 21
Silver Spring 21
Athens 20
Nanchang 20
Turku 20
Genoa 19
Hebei 19
Montreal 19
Pune 19
Rio de Janeiro 19
Florence 18
Düsseldorf 17
Warsaw 17
Zhengzhou 17
Gainesville 16
Johannesburg 16
Mumbai 16
Nairobi 16
Stockholm 16
Sydney 16
Wuhan 16
Boston 15
Chengdu 15
Bexley 14
Brooklyn 14
Totale 15.569
Salva come PNG Salva come JPEG
Nome #
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management 706
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients : a retrospective analysis 457
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 376
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 340
Schwann cell hamartoma: case report 327
Computational pathology to improve biomarker testing in breast cancer: how close are we? 322
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer 308
Targeting immune-related biological processes in solid tumors : we do need biomarkers 302
Hereditary gastric and breast cancer syndromes related to CDH1 germline mutation: A multidisciplinary clinical review 302
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors : a comprehensive analysis with clinicopathologic and molecular correlations 292
Pten alterations and their role in cancer management: Are we making headway on precision medicine? 285
E-cadherin deregulation in breast cancer 284
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer 272
Circulating and tissue biomarkers in early-stage non-small cell lung cancer 265
Standard operating procedures for biobank in oncology 264
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology 258
Comprehensive genomic analysis reveals the prognostic role of LRRK2 copy-number variations in human malignancies 256
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 251
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages 250
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review 245
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients 242
The oncofetal protein IMP3 : a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung 238
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes 233
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® 224
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record 223
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer 222
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial 219
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up 217
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach 214
Mismatch repair-deficient hormone receptor-positive breast cancers : Biology and pathological characterization 212
HER2 in gastric cancer : a digital image analysis in pre-neoplastic, primary and metastatic lesions 211
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study 211
Contrast-enhanced computed tomography colonography in preoperative distinction between T1-T2 and T3-T4 staging of colon cancer 208
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma 208
A role for the immune system in advanced laryngeal cancer 207
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 204
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype 202
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling 202
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy 199
The Genomic Landscape of Male Breast Cancers 197
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact 195
In-house homologous recombination deficiency testing in ovarian cancer: A multi-institutional Italian pilot study 192
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management 192
Understanding EGFR heterogeneity in lung cancer 191
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment 190
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer : Results from the SOLE Trial 188
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles 187
Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis 185
Successful treatment with avapritinib in patient with mucosal metastatic melanoma 185
Integrated analysis of mismatch repair, PD-L1, and immune microenvironment status in pregnancy-associated breast cancers 184
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients : a pilot study 181
Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma' 180
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies 176
The birth of an adenoid cystic carcinoma 173
Dynamic retention of Ero1α and Ero1β in the endoplasmic reticulum by interactions with PDI and ERp44 173
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features 173
Hibernation in Unusual Places: A Pure Typical Hibernoma of the Breast 172
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 171
Rediscovering secondary tumors of the prostate in the molecular era 170
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00 169
Complex differential diagnosis between primary breast cancer and breast metastasis from egfr-mutated lung adenocarcinoma: Case report and literature review 168
A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer 167
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. : Clinical outcome and actionable molecular alterations 165
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer 164
Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis 163
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene 161
Whole-Exome and RNA-Sequencing Analyses of Acinic Cell Carcinomas of the Breast 161
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 160
Small cell carcinoma of the gynecologic tract : a multifaceted spectrum of lesions 158
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking 156
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis 155
Trop-2 as an Actionable Biomarker in Breast Cancer 154
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 154
Lobular carcinoma in situ : a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk 149
Inter-tumor genomic heterogeneity of breast cancers : comprehensive genomic profile of primary early breast cancers and relapses 149
Making the most of complexity to create opportunities: Comprehensive genomic profiling and molecular tumor board for patients with non-small cell lung cancer (NSCLC) 149
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement 146
PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma 145
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods 144
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes 144
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy 143
Molecular tumor board in patients with metastatic breast cancer 140
High-risk human papillomavirus in anal squamous cell carcinoma : a 'conservative' leading role 140
Letter to the Editor 139
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 139
The molecular landscape of breast mucoepidermoid carcinoma 138
Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis 138
Proposal for integrating the pathologic assessment of lymphovascular invasion and extranodal tumor extension in breast cancer-related lymphedema clinical management 137
Reproducibility of mrna-based testing of esr1, pgr, erbb2, and mki67 expression in invasive breast cancer—a europe-wide external quality assessment 137
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience 136
Genomic characterization of concurrent alterations in non-small cell lung cancer (Nsclc) harboring actionable mutations 136
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores 136
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test 134
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists 134
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis 133
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing 133
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ 132
Implementing digital pathology: qualitative and financial insights from eight leading European laboratories 131
Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers : the Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples 130
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy 130
Totale 20.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021194 0 0 0 0 0 0 0 0 0 0 82 112
2021/20221.119 98 75 48 71 85 72 72 82 134 92 54 236
2022/20231.252 150 121 118 124 105 241 57 73 134 11 80 38
2023/20243.300 44 78 70 67 213 181 523 466 223 409 510 516
2024/20255.279 463 555 468 468 270 216 219 437 331 436 449 967
2025/202610.533 1.130 1.225 1.656 935 792 595 1.308 551 1.006 725 610 0
Totale 24.571